NDC 85043-045 – Vabrinty
Leuprolide Acetate 45 mg/.375mL · Injection, Suspension, Extended Release · Subcutaneous
Product NDC85043-045
Product details
- Brand name
- Vabrinty
- Generic name
- Leuprolide acetate
- Labeler
- URONOVA PHARMACEUTICALS, INC.
- Dosage form
- Injection, Suspension, Extended Release
- Route
- Subcutaneous
- Marketing category
- NDA AUTHORIZED GENERIC · NDA021731
- Marketed since
- August 4, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Gonadotropin Releasing Hormone Receptor Agonist
Active ingredients
- Leuprolide Acetate 45 mg/.375mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 85043-045-04 | 1 SYRINGE in 1 CARTON (85043-045-04) / .375 mL in 1 SYRINGE | Aug 4, 2025 |
Other Vabrinty products
- 85043-025 Leuprolide Acetate 22.5 mg/.375mL · Injection, Suspension, Extended Release · URONOVA PHARMACEUTICALS, INC.
- 85043-030 Leuprolide Acetate 30 mg/.5mL · Injection, Suspension, Extended Release · URONOVA PHARMACEUTICALS, INC.
- 85043-075 Leuprolide Acetate 7.5 mg/.25mL · Injection, Suspension, Extended Release · URONOVA PHARMACEUTICALS, INC.